R.P. Boggs & Co. Regeneron Pharmaceuticals, Inc. Transaction History

R.P. Boggs & Co.

$150 Million
Q2 2025

A detailed history of R.P. Boggs & Co. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, R.P. Boggs & Co. holds 29,676 shares of REGN stock, worth $16.7 Million. This represents 10.38% of its overall portfolio holdings.

Number of Shares

29,676

Previous 9,670 206.89%

Holding current value

$16.7 Million

Previous $6.13 Million 154.02%

% of portfolio

10.38%

Previous 4.37%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	BUY	$483.07 - $625.6 $9.66 Million - $12.5 Million	20,006 Added 206.89%	29,676 $15.6 Million
Q1 2025 Apr 29, 2025	BUY	$634.14 - $744.83 $247,948 - $291,228	391 Added 4.21%	9,670 $6.13 Million
Q4 2024 Jan 29, 2025	BUY	$701.85 - $1046.91 $268,808 - $400,966	383 Added 4.31%	9,279 $6.61 Million
Q3 2024 Oct 18, 2024	BUY	$1024.09 - $1201.76 $27,650 - $32,447	27 Added 0.3%	8,896 $9.35 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $6.34 Million - $7.7 Million	-7,184 Reduced 44.75%	8,869 $9.32 Million
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $122,765 - $135,095	-136 Reduced 0.84%	16,053 $15.5 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $156,586 - $178,103	202 Added 1.26%	16,189 $14.2 Million
Q3 2023 Nov 09, 2023	BUY	$692.45 - $844.37 $9,694 - $11,821	14 Added 0.09%	15,987 $13.2 Million
Q2 2023 Nov 16, 2023	BUY	$700.03 - $830.35 $4.7 Million - $5.58 Million	6,721 Added 72.64%	15,973 $11.5 Million
Q2 2023 Jul 27, 2023	BUY	$700.03 - $830.35 $4.7 Million - $5.58 Million	6,721 Added 72.64%	15,973 $11.5 Million
Q1 2023 Nov 16, 2023	SELL	$680.49 - $826.97 $4.58 Million - $5.57 Million	-6,735 Reduced 42.13%	9,252 $7.6 Million
Q1 2023 May 02, 2023	SELL	$680.49 - $826.97 $2,041 - $2,480	-3 Reduced 0.03%	9,252 $7.6 Million
Q4 2022 Jan 25, 2023	SELL	$705.89 - $766.39 $5,647 - $6,131	-8 Reduced 0.09%	9,255 $6.68 Million
Q3 2022 Oct 14, 2022	BUY	$573.97 - $724.32 $48,787 - $61,567	85 Added 0.93%	9,263 $6.38 Million
Q2 2022 Jul 28, 2022	BUY	$548.35 - $738.84 $117,895 - $158,850	215 Added 2.4%	9,178 $5.43 Million
Q1 2022 Apr 25, 2022	BUY	$595.12 - $698.43 $6,546 - $7,682	11 Added 0.12%	8,963 $6.26 Million
Q4 2021 Jan 31, 2022	BUY	$543.48 - $670.97 $100,000 - $123,458	184 Added 2.1%	8,952 $5.65 Million
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $5.03 Million - $5.97 Million	8,768 New	8,768 $5.31 Million

Others Institutions Holding REGN

# of Institutions

1,417

Shares Held

88.7M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $60.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of R.P. Boggs & Co., based on Form 13F filings with the SEC.

News

Stay updated on R.P. Boggs & Co. with notifications on news.

Account